Cargando…
90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
Glycoprotein 90K, encoded by the interferon-stimulated gene LGALS3BP, displays broad antiviral activity. It reduces HIV-1 infectivity by interfering with Env maturation and virion incorporation, and increases survival of Influenza A virus-infected mice via antiviral innate immune signaling. Its anti...
Autores principales: | Bosquillon de Jarcy, Laure, Akbil, Bengisu, Mhlekude, Baxolele, Leyens, Johanna, Postmus, Dylan, Harnisch, Greta, Jansen, Jenny, Schmidt, Marie L., Aigner, Annette, Pott, Fabian, Chua, Robert Lorenz, Krist, Lilian, Gentile, Roberta, Mühlemann, Barbara, Jones, Terence C., Niemeyer, Daniela, Fricke, Julia, Keil, Thomas, Pischon, Tobias, Janke, Jürgen, Conrad, Christian, Iacobelli, Stefano, Drosten, Christian, Corman, Victor M., Ralser, Markus, Eils, Roland, Kurth, Florian, Sander, Leif, Goffinet, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170455/ https://www.ncbi.nlm.nih.gov/pubmed/37162650 http://dx.doi.org/10.1007/s10238-023-01077-2 |
Ejemplares similares
-
Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection
por: Mhlekude, Baxolele, et al.
Publicado: (2023) -
Prognostic relevance of LGALS3BP in human colorectal carcinoma
por: Piccolo, Enza, et al.
Publicado: (2015) -
Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2013) -
Nonproductive exposure of PBMCs to SARS‐CoV‐2 induces cell‐intrinsic innate immune responses
por: Kazmierski, Julia, et al.
Publicado: (2022) -
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
por: Capone, Emily, et al.
Publicado: (2020)